Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)
Stopped Trial terminated because of lack of efficacy in the short term acute phase.
Conditions
- Nonalcoholic Steatohepatitis (NASH)
Interventions
- DRUG: BMS-986263
- OTHER: Placebo
Sponsor
Bristol-Myers Squibb